Abbott Laboratories ABT
NYSE ABT
$105.46 -0.06 (-0.06%)
As of: Sep 9, 2026 · 3:28 PM EDT

Abbott Laboratories (ABT) Operating Margin Growth (3y) (2012 - 2026)

Analysis

Abbott Laboratories (ABT) Operating Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.43 Bn 177.83 Bn 7.27 Bn -201.00
2 Intuitive Surgical 124.55 Bn 119.33 Bn 1.96 Bn 722.00
3 Medtronic 117.91 Bn 109.10 Bn 6.34 Bn 162.00
4 Stryker 105.51 Bn 102.03 Bn 4.50 Bn 586.00
5 Boston Scientific 66.23 Bn 65.69 Bn 3.85 Bn 736.00
6 Edwards Lifesciences 49.46 Bn 45.21 Bn 1.35 Bn 887.00
7 Alcon 33.87 Bn 32.41 Bn 1.68 Bn -1,075.00
8 Dexcom 32.08 Bn 30.13 Bn 830.00 Mn 963.00
9 Steris 21.05 Bn 20.56 Bn 684.20 Mn 244.00
10 Zimmer Biomet Holdings 18.27 Bn 17.86 Bn 1.54 Bn -265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -201.00
Mar 31, 2026 -343.00
Dec 31, 2025 672.00
Sep 30, 2025 109.00
Jun 30, 2025 -269.00
Mar 31, 2025 -814.00
Dec 31, 2024 -332.00
Sep 30, 2024 -582.00
Jun 30, 2024 247.00
Mar 31, 2024 -626.00
Dec 31, 2023 -535.00
Sep 30, 2023 -65.00
Jun 30, 2023 628.00
Mar 31, 2023 567.00
Dec 31, 2022 -378.00
Sep 30, 2022 217.00
Jun 30, 2022 599.00
Mar 31, 2022 1,467.00
Dec 31, 2021 573.00
Sep 30, 2021 1,030.00